EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders

Hiroshi Kitamura iD

International Journal of Molecular Sciences · 06.02.2023 · 24 (4) · 3219

DOI: 10.3390/ijms24043219 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.02.2023. Verfasst von Hiroshi Kitamura. Beteiligte Einrichtung: Laboratory of Comparative Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan. Hauptthemen laut MEDLINE: Ubiquitin-Specific Proteases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 251 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. USP22 in pancreatic β-cells, USP2 in adipose tissue macrophages, USP9X, 20, and 33 in myocytes, USP4, 7, 10, and 18 in hepatocytes, and USP2 in hypothalamus improve hyperglycemia, whereas USP19 in adipocytes, USP21 in myocytes, and USP2, 14, and 20 in hepatocytes promote hyperglycemia. In contrast, USP1, 5, 9X, 14, 15, 22, 36, and 48 modulate the progression of diabetic nephropathy, neuropathy, and/or retinopathy. USP4, 10, and 18 in hepatocytes ameliorates non-alcoholic fatty liver disease (NAFLD), while hepatic USP2, 11, 14, 19, and 20 exacerbate it. The roles of USP7 and 22 in hepatic disorders are controversial. USP9X, 14, 17, and 20 in vascular cells are postulated to be determinants of atherosclerosis. Moreover, mutations in the Usp8 and Usp48 loci in pituitary tumors cause Cushing syndrome. This review summarizes the current knowledge about the modulatory roles of USPs in energy metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Specific ProteasesNon-alcoholic Fatty Liver DiseaseHumansUbiquitinationHepatocytesUbiquitin ThiolesteraseUbiquitin-Specific Peptidase 7Endopeptidases

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasediabetesinsulin resistancemetabolic disordernon-alcoholic fatty liver diseaseobesityubiquitin-specific protease

Substanzen

Ubiquitin-Specific ProteasesUbiquitin ThiolesteraseUSP21 protein, humanUSP7 protein, humanUbiquitin-Specific Peptidase 7USP4 protein, humanUSP9X protein, humanUsp22 protein, humanUSP19 protein, humanEndopeptidases

Autor:innen und Institutionen

  • Laboratory of Comparative Medicine, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu 069-8501, Japan.

ORCID-Profile: Hiroshi Kitamura

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kitamura, H. (2023). Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. International Journal of Molecular Sciences, 24(4), 3219. https://doi.org/10.3390/ijms24043219

Vancouver

Kitamura H. Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders. International Journal of Molecular Sciences. 2023;24(4):3219. doi:10.3390/ijms24043219

BibTeX
@article{Kitamura2023,
  author = {Kitamura, Hiroshi},
  title = {Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3219},
  doi = {10.3390/ijms24043219}
}
Kostenlos starten →